Risk of metachronous peritoneal metastases after surgery for obstructive colon cancer: Multivariate analysis from a series of 1,085 patients

Authors: Abba, J., Alfarai, A., d’Annunzio, E., Arvieux, C., Badic, B., Aumont, A., Balbo, G., Baque, P., Baraket, O., Bege, T., Bellinger, J., Bert, M., Bertrand, M., Beyer-Berjot, L., Blanc, B., Brouquet, A., Brunetti, F., Cabau, M., Catheline, J.M., Cazauran, J.B., Chatelain, E., Chau, A., Codjia, T., Collard, M., Corte, H., Couchard, A.C., David, A., Dazza, M., Dejeante, C., De La Villéon, B., Denost, Q., Diaz de Cerio, J.M., Djawad-Boumediene, B., Dubuisson, V., Duchalais, E., Dufour, F., Dumaine, A.S., Esposito, F., Etienne, J.C., Eveno, C., Fayssal, E., Fernoux, P., Fixot, K., Fuks, D., Gagnat, G., Goin, G., Goudard, Y., Grégoire, E., Guillem, P., Hamel, S., Heyd, B., Huart, E., Humeau, M., Issard, J., Jafar, Y., Kadoche, D., Kahn, X., Lacaze, L., Lailler, G., Lefèvre, J.H., Lizzi, V., Loge, L., Lupinacci, R., Mabrut, J.Y., Maes, B., Maggiori, L., Mallet, L., Mariol, P., Martre, P., Mauvais, F., Messière, A.S., Michot, N., Moszkowicz, D., Munoz, N., Ortega-Deballon, P., Paquette, B., Parc, Y., Pauleau, G., Pautrat, K., Peschaud, F., Philouze, G., Pichot-Delahaye, V., Piessen, G., Pitel, S., Rat, P., Regimbeau, J.M., Rivier, P., Roussel, E., Sage, P.Y., de Saint Roman, C., Sockeel, P., Susoko, L., Tetard, O., Tortajada, P., Tranchart, A., Tresallet, C., Trilling, B., Ulloa-Severino, B., Vauchaussade de Chaumont, A., Venara, A., Cazelles, Antoine ^a, Tarhini, Ahmad ^a, Sabbagh, Charles ^b, Mege, Diane ^c, Bridoux, Valérie ^d, Lakkis, Zaher ^e, Voron, Thibault ^f, Abdalla, Solafah ^g, Lecot, Frederik ^a, Karoui, Mehdi ^a, Manceau, Gilles ^{a, ∗}

Source: In Surgery February 2025 178

Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages

Authors: Mandula, Jay K. ^{1, 11}, Sierra-Mondragon, Rosa A. ^{1, 11}, Jimenez, Rachel V. ^{1, 11}, Chang, Darwin ¹, Mohamed, Eslam ², Chang, Shiun ¹, Vazquez-Martinez, Julio A. ¹, Cao, Yu ¹, Anadon, Carmen M. ³, Lee, Sae Bom ¹, Das, Satyajit ¹, Rocha-Munguba, Léo ¹, Pham, Vincent M. ¹, Li, Roger ⁴, Tarhini, Ahmad A. ^{1, 5}, Furqan, Muhammad ⁶, Dalton, William ⁷, Churchman, Michelle ⁷, Moran-Segura, Carlos M. ⁸, Nguyen, Jonathan ⁸, Perez, Bradford ¹, Kojetin, Douglas J. ⁹, Obermayer, Alyssa ¹⁰, Yu, Xiaoqing ¹⁰, Chen, Ann ¹⁰, Shaw, Timothy I. ^{1, 10}, Conejo-Garcia, Jose R. ³, Rodriguez, Paulo C. ^{1, 12, ∗}

Source: In Immunity 14 May 2024 57(5):1124-1140

Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients

Authors: Betof Warner, Allison, Tarhini, Ahmad, Kang, Barinder, Nakasato, Antonio, Ling, You-Li, Shah, Rohan, Tang, Jackson, Patel, Jeetvan

Source: Melanoma research. 33(1):38-49

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100188596218.0x000001&indx=1&recIds=ETOCvdc_100188596218.0x000001

Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients

Authors: Eroglu, Zeynep, Krinshpun, Shifra, Kalashnikova, Ekaterina, Sudhaman, Sumedha, Ozturk Topcu, Turkan, Nichols, Matt, Martin, Justin, Bui, Katherine M., Palsuledesai, Charuta C., Malhotra, Meenakshi, Olshan, Perry, Markowitz, Joseph, Khushalani, Nikhil I., Tarhini, Ahmad A., Messina, Jane L., Aleshin, Alexey

Source: Cancer. 129(11):1723-1734

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182220411.0x000001&indx=1&recIds=ETOCvdc_100182220411.0x000001

Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma

Authors: Coleman, Samuel, Xie, Mengyu, Tarhini, Ahmad A., Tan, Aik Choon

Source: Molecular carcinogenesis. 62(1):77-89

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100170811910.0x000001&indx=1&recIds=ETOCvdc_100170811910.0x000001

Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial

Authors: Kim, Sungjune, Wuthrick, Evan, Blakaj, Dukagjin, Eroglu, Zeynep, Verschraegen, Claire, Thapa, Ram, Mills, Matthew, Dibs, Khaled, Liveringhouse, Casey, Russell, Jeffery, Caudell, Jimmy J, Tarhini, Ahmad, Markowitz, Joseph, Kendra, Kari, Wu, Richard, Chen, Dung-Tsa, Berglund, Anders, Michael, Lauren, Aoki, Mia, Wang, Min-Hsuan, Hamaidi, Imene, Cheng, Pingyan, de la Iglesia, Janis, Slebos, Robbert J, Chung, Christine H, Knepper, Todd C, Moran-Segura, Carlos M, Nguyen, Jonathan V, Perez, Bradford A, Rose, Trevor, Harrison, Louis, Messina, Jane L, Sondak, Vernon K, Tsai, Kenneth Y, Khushalani, Nikhil I, Brohl, Andrew S

Source: Lancet. 400(10357):1008-1019

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190064428.0x000001&indx=1&recIds=ETOCvdc_100190064428.0x000001

The treatment of advanced melanoma: a review of systemic and local therapies in combination with immune checkpoint inhibitors in phase 1 and 2 clinical trials

Authors: DePalo, Danielle K., Tarhini, Ahmad, Zager, Jonathan S.

Source: Expert opinion on investigational drugs. 31(1):95-104

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100141731537.0x000001&indx=1&recIds=ETOCvdc_100141731537.0x000001

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Authors: Atkins, Michael B., Lee, Sandra J., Chmielowski, Bartosz, Tarhini, Ahmad A., Cohen, Gary I., Truong, Thach-Giao, Moon, Helen H., Davar, Diwakar, O'Rourke, Mark, Stephenson, Joseph J., Curti, Brendan D., Urba, Walter J., Brell, Joanna M., Funchain, Pauline, Kendra, Kari L., Ikeguchi, Alexandra P., Jaslowski, Anthony, Bane, Charles L., Taylor, Mark A., Bajaj, Madhuri, Conry, Robert M., Ellis, Robert J., Logan, Theodore F., Laudi, Noel, Sosman, Jeffrey A., Crockett, David G., Pecora, Andrew L., Okazaki, Ian J., Reganti, Sowjanya, Chandra, Sunandana, Guild, Samantha, Chen, Helen X., Streicher, Howard Z., Wolchok, Jedd D., Ribas, Antoni, Kirkwood, John M.

Source: Journal of clinical oncology. 41(2):186-197

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179829888.0x000001&indx=1&recIds=ETOCvdc_100179829888.0x000001

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors

Authors: Mantia, Charlene M., Werner, Lillian, Stwalley, Brian, Ritchings, Corey, Tarhini, Ahmad A., Atkins, Michael B., McDermott, David F., Regan, Meredith M.

Source: Melanoma research. 32(1):35-44

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179640235.0x000001&indx=1&recIds=ETOCvdc_100179640235.0x000001

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study

Authors: Tawbi, Hussein A ^*, Forsyth, Peter A, Hodi, F Stephen, Algazi, Alain P, Hamid, Omid, Lao, Christopher D, Moschos, Stergios J, Atkins, Michael B, Lewis, Karl, Postow, Michael A, Thomas, Reena P, Glaspy, John, Jang, Sekwon, Khushalani, Nikhil I, Pavlick, Anna C, Ernstoff, Marc S, Reardon, David A, Kudchadkar, Ragini, Tarhini, Ahmad, Chung, Caroline, Ritchings, Corey, Durani, Piyush, Askelson, Margarita, Puzanov, Igor, Margolin, Kim A

Source: In The Lancet Oncology December 2021 22(12):1692-1704

Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma

Authors: Khunger, Arjun, Sarikonda, Ghanashyam, Tsau, Jennifer, Pahuja, Anil, Alfonso, Zeni, Gao, Jane, Laing, Christian, Vaupel, Christine, Dakappagari, Naveen, Tarhini, Ahmad A.

Source: In Translational Oncology March 2021 14(3)

Adjuvant Therapy of Melanoma

Authors: Tarhini, Ahmad A.

Source: In Hematology/Oncology Clinics of North America February 2021 35(1):73-84

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Authors: Tawbi, Hussein A, Forsyth, Peter A, Hodi, F Stephen, Lao, Christopher D, Moschos, Stergios J, Hamid, Omid, Atkins, Michael B, Lewis, Karl, Thomas, Reena P, Glaspy, John A, Jang, Sekwon, Algazi, Alain P, Khushalani, Nikhil I, Postow, Michael A, Pavlick, Anna C, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Tarhini, Ahmad A, Sumbul, Anne, Rizzo, Jasmine I, Margolin, Kim A

Source: Neuro-oncology. 23(11):1961-1973

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100133219307.0x000001&indx=1&recIds=ETOCvdc_100133219307.0x000001

Multidisciplinary Care of BRAF‐Mutant Stage III Melanoma: A Physicians Perspective Review

Authors: Cornelius, Lynn A., Fields, Ryan C., Tarhini, Ahmad

Source: Oncologist. 26(9):e1644-e1651

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100129260783.0x000001&indx=1&recIds=ETOCvdc_100129260783.0x000001

Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry

Authors: Edgar, Robert H., Tarhini, Ahmad, Sander, Cindy, Sanders, Martin E., Cook, Justin L., Viator, John A.

Source: Lasers in surgery and medicine. 53(4):578-586

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120157252.0x000001&indx=1&recIds=ETOCvdc_100120157252.0x000001

Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma

Authors: Tarhini, Ahmad A, Joshi, Ila, Garner, Fiona

Source: Immunotherapy. 13(12):1011-1029

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190010360.0x000001&indx=1&recIds=ETOCvdc_100190010360.0x000001

Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold technique

Authors: Mansfield, Carol, Myers, Kelley, Klein, Kathleen, Patel, Jeetvan, Nakasato, Antonio, Ling, You-Li, Tarhini, Ahmad A

Source: Future oncology. 17(17):2151-2167

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187789121.0x000001&indx=1&recIds=ETOCvdc_100187789121.0x000001

70 - Immunological and Cell-Based Therapies

Authors: Topcu, Turkan Ozturk, Kobeissi, Iyad, Tarhini, Ahmad

Source: In Brody's Human Pharmacology Edition: Seventh Edition. 2025:663-670

Higgs quartic coupling and neutrino sector evolution in 2UED models

Authors: Abdalgabar, Ammar, Cornell, Alan S., Deandrea, Aldo, Tarhini, Ahmad

Subject Terms: High Energy Physics - Phenomenology

Access URL: http://arxiv.org/abs/1307.6401

Evolution of Yukawa couplings and quark flavour mixings in 2UED models

Authors: Abdalgabar, Ammar, Cornell, A. S., Deandrea, Aldo, Tarhini, Ahmad

Subject Terms: High Energy Physics - Phenomenology

Access URL: http://arxiv.org/abs/1306.4852